Cue Biopharma
CUE
CUE
29 hedge funds and large institutions have $25.9M invested in Cue Biopharma in 2018 Q1 according to their latest regulatory filings, with 29 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
29
Holders Change
+29
Holders Change %
–
% of All Funds
0.67%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
29
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
First Eagle Investment Management
New York
|
$7.03M |
2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$6.35M |
3 |
3
BlackRock
New York
|
$5.55M |
4 |
4
State Street
Boston,
Massachusetts
|
$1.66M |
5 |
5
Northern Trust
Chicago,
Illinois
|
$1.06M |
Top Sellers
No sellers this quarter